CTB10 - New and Future Developments Flashcards

1
Q

Name some factors that are changing globally, which may impact cardio respiratory conditions.

A
Environmental pollution.
Smoking.
Diet.
Ageing population.
Technology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss the advantages and disadvantages associated with technology in healthcare.

A

Advantages - can make healthcare more accessible, in terms of delivery andmonitoring
Disadvantages - effect of non compliance can increase with increasing social media.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss alternative and complementary medicine.

A

Use of non standard healthcare I.e. acupuncture, herbal medicines, home treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define precision medicine,

A

Also referred to as personalised medicine. Involves the targeting of medical treatments to specific sub populations within a disease population. Can make treatment processes more beneficial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What kind of processes will be personalised during personalised medicine?

A

Customisation of medical practices. Diagnosis. Decisions. Treatments. Products.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What kind of patient specific products may be designed as part of personalised medicine?

A

Patient specific tissues or organs built from patients own cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the process from one size fits all medicine to stratified medicine to precision medicine.

A

From one size fits all medicine to stratified medicine requires stratification - disease population grouped into sub populations based on demographics, clinical features and bio markers.
Stratified medicine to personalised medicine requires personalisation - individual preferences considered, genetic profile, medication history, environment, behaviour, habits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are three factors that are considered when identifying sub populations within a disease population?

A

Disease susceptibility.
Disease prognosis/biology.
Response to treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give a brief overview of the process of drug development.d

A

Many thousands of compounds originally screen during stage 1 drug discovery which involves in vitro testing. Hundreds of these are taken to pre clinical development stage 2 which involves animal testing. A handful of these are taken to stage 3 clinical development with human testing (5 phases within this). One compound may come out of this which needs to undergo regulatory approval. Overall process for each drug can take approx 15 years and 3 billion dollar.s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss the advantages and disadvantages of in vitro testing during pre clinical development.

A

Advantages - easy to do, can be reproducible between different laboratories around the world.
Disadvantages - inefficient, does not display true behaviour of the drug, time consuming.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss advantages and disadvantages of animal testing.

A

Advantages - may be representative of how drug effects humans also, relatively cheap,
Disadvantages - not ethical to test on animals,animal disease model does not fully indicate how disease behaves in humans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What issue do organs on chips hope to overcome? How does it do this?

A

Use of animal testing. Organ on chip behaves as artificial human that can be used for testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give four advantages of the organ on a chip system.

A

Multiple drug testing is more readily doable.
Reduced experimental use of animals.
Personalised medicine more accessible.
Drug toxicity can be evaluated prior to administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss briefly the structure of an organ on a chip, using the pulmonary artery on a chip as an example.

A

Microscopic sized channel crested with polydimethylsiloxane used to make chambers and membranes. One side of membrane contains endothelial cells and other contains smooth muscle cells. Blood flow is stimulated within the chamber.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define bioprinting.

A

Printing of 3D images using living cells as the ink for printing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Define bio fabrication.

A

Use of technology and engineering to produce tissues and organs.

17
Q

What are some problems currently associated with bioprinting?

A

Formation of blood vessels and intercellular connections.

18
Q

Give one example of the use of bioprinting within a human patient.

A

Production of airway splint from bioresorbable plastics. Used in 3 month old baby to hold airway open ensuring sufficient breathing.

19
Q

What current transplantation issues could bioprinting potentially alleviate?

A

Rejection of transplant organ - if organ being transplanted is made from patients own cells, reduces risk of rejection, if any. Removes need for use of immunosuppressants.
Lack of transplant availability - transplant list is ever growing however donor list is not. Using own patients cells may mean that waiting times are reduced.

20
Q

What two processes may be combined alongside bioprinting to deliver modified cells via therapeutic means?

A

Gene transcription and drug delivery.

21
Q

Discuss the potential use of bioprinting on the patient.

A

Direct bioprinting on the patient may be used for direct wound repairing. Requires use of growth factor and other biomaterial scaffolds.

22
Q

What are eNoses and how have they been developed to work efficiently?

A

Electronic noses that are able to recognise and detect specific smells. Use a current database to match the smell to one that is already known and has been previously identified.

23
Q

Give a use of the eNose in a clinical setting.

A

Can be used to detect respiratory disease. Can be extremely helpful for early detection.

24
Q

What two lung disease can most commonly be differentiated between using eNose?

A

COPD and asthma

25
Q

In addition to COPD and asthma, what other types of lung diseases are more recently being distinguished via eNose?

A

Lung cancer - eNose detects volatile organic compounds within the exhaled air and matches to a type of cancer.
Viral and bacterial infections - can be used to identify the specific type of COPD exacerbation.

26
Q

Discuss the use of the iKnife in cancer surgical procedures.

A

Cutting tool is heated and brought into contact with the cancerous cells. Rapid evaporative ionisation mass spectrometer (REIMS) used to chemically analyse the smoke produced from the hot cutting tool. Presence or absence of cancer cells is detected and information relayed to surgeon. Allows easy detection of cancer vs non cancer.

27
Q

What are three major areas within cardio respiratory medicine that are currently being researched?

A

More accurate diagnostics processes.
New therapies and delivery devices.
Artificial intelligence and machine learning.

28
Q

What is diagnostics? Discuss its importance in precision medicine.

A

Diagnostics refers to the process by which a disease can be diagnosed within a patient. Can be particularly useful in personalised medicine to detect sub populations within a disease population,

29
Q

What are LRTIs and why is diagnostics important within this area of medicine?

A

LRTIs are lower respiratory tract infections. Many different types are apparent but are difficult To diagnose and distinguish. Additional processes are being built to distinguish between them ,ensuring that more accurate treatment processes can be performed

30
Q

What other parameters may be used for diagnostics?

A

Current parameters used need to be fine tuned or new parameters need to be considered. E.g. respiratory diseases can be identified using FEV1/FVC ratios and patient reported outcomes however these can be refined

31
Q

What are three current difficulties associated with drug delivery?

A

Delivery to optimal region within the system.
Delivery to region at optimal concentration.
Prevention of unwanted side effects - E.g. by preventing drug entering systemic circulation

32
Q

Discuss the use of tracking patient medication adherence and its importance.

A

Tracking patient adherence can be used to determine if the medication is having an effect or not. If patient not using medication, perhaps another medication could be trialled. Costs associated with healthcare may also be reduced.

33
Q

Discuss what green healthcare is.

A

Use of environmentally friendly processes within the field of healthcare. E.g. use of disposable plastic inhalers for respiratory conditions

34
Q

Discuss the two potential uses of AI and machine learning during CT scans.

A

Improving obtaining the CT scan images. Improving interpreting the CT scan images.

35
Q

Discuss the role of AI and machine learning in iKnife and eNose?

A

IKnife - can be used to distinguish between cancerous and non cancerous cells.
ENose - can be used to distinguish between different smells.